MINE in the context of chemotherapy is an acronym for one of the chemotherapy regimens used for treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
Today this regimen is often combined with monoclonal antibody rituximab.
In this case the regimen is called R-MINE or MINE-R.[citation needed] The [R]-MINE regimen consists of: